4//SEC Filing
DelAversano Robert J 4
Accession 0001493152-20-010512
CIK 0001444307other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:16 PM ET
Size
8.7 KB
Accession
0001493152-20-010512
Insider Transaction Report
Form 4
DelAversano Robert J
Principal Accounting Officer
Transactions
- Tax Payment
Common Stock
2020-05-29$2.23/sh−8,679$19,354→ 16,683 total - Award
Common Stock
2020-05-29+25,362→ 25,362 total - Award
Stock Option (Right to Buy)
2020-05-29+54,054→ 54,054 totalExercise: $1.56From: 2020-04-14Exp: 2030-04-14→ Common Stock (54,054 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Issuer's Compensation Committee on April 14, 2020, subject to stockholder approval of an amendment to the Issuer's 2011 Incentive Plan to increase the number of authorized shares. The Issuer's stockholders approved the plan amendment on May 29, 2020.
- [F2]The option was 25% vested on April 14, 2020, and the remainder vests quarterly over the next three years.
Documents
Issuer
ONCOSEC MEDICAL Inc
CIK 0001444307
Entity typeother
Related Parties
1- filerCIK 0001728262
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:16 PM ET
- Size
- 8.7 KB